COVID-19 and the problem of clinical knowledge

History and Philosophy of the Life Sciences 43 (2):1-5 (2021)
  Copy   BIBTEX

Abstract

COVID-19 presents many challenges, both clinical and philosophical. In this paper we discuss a major lacuna that COVID-19 revealed in our philosophy and understanding of medicine. Whereas we have some understanding of how physician-scientists interrogate the world to learn more about medicine, we do not understand the epistemological costs and benefits of the various ways clinicians acquire new knowledge in their fields. We will also identify reasons this topic is important both when the world is facing a pandemic and when it is not.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 90,593

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Dying during Covid‐19.Bryanna Moore - 2020 - Hastings Center Report 50 (3):13-15.
What’s happening in open science?Adeline Rosenberg - 2020 - Weekly Digest Open Pharma 2020 (6).
Learning from Covid.Adira Hulkower - 2020 - Hastings Center Report 50 (3):16-17.

Analytics

Added to PP
2021-04-01

Downloads
11 (#975,863)

6 months
3 (#445,838)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Jeremy R. Simon
Columbia University

References found in this work

Making Medical Knowledge.Miriam Solomon - 2015 - Oxford: Oxford University Press.
Mechanisms: what are they evidence for in evidence-based medicine?Holly Andersen - 2012 - Journal of Evaluation in Clinical Practice 18 (5):992-999.
Why There’s No Cause to Randomize.John Worrall - 2007 - British Journal for the Philosophy of Science 58 (3):451-488.
What are randomised controlled trials good for?Nancy Cartwright - 2010 - Philosophical Studies 147 (1):59 - 70.

View all 7 references / Add more references